Haupt R, Comelli A, Rosanda C, Sessarego M, De Bernardi B
Department of Hematology-Oncology, G. Gaslini Children's Hospital, Genova, Italy.
Am J Pediatr Hematol Oncol. 1993 May;15(2):255-7. doi: 10.1097/00043426-199305000-00015.
The first case of secondary leukemia (FAB M3 microgranular variant) after single-agent chemotherapy with etoposide is described. The peculiar morphology and the absence of previously described cytogenetic abnormalities make this case of interest and emphasize the need for further study of epipodophyllotoxin-related leukemia.
本文描述了首例接受依托泊苷单药化疗后发生的继发性白血病(FAB M3微颗粒变异型)。其独特的形态以及未出现先前描述的细胞遗传学异常,使得该病例具有研究价值,并强调了对表鬼臼毒素相关白血病进行进一步研究的必要性。